All In Biotech

Drug Trial Radar · NCT01908140

Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Randomised, Double-blind, Double-dummy, Active-controlled Study Evaluating the Efficacy, Safety and Tolerability of Twice-daily Aclidinium Bromide/Formoterol Fumarate Compared With Twice-daily Salmeterol/Fluticasone Propionate for 24 Weeks Treatment in Symptomatic Patients With Chronic Obstructive Pulmonary Disease (COPD)

Last checked: Nov 19, 2026Latest source record: Mar 7, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 933 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

933

Actual

Start

Sep 2013

Primary completion

Aug 2014

Study completion Aug 2014

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jul 25, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare the efficacy, safety and tolerability of aclidinium bromide/formoterol fumarate and salmeterol/fluticasone propionate in patients with chronic obstructive pulmonary disease (COPD)

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

  • Aclidinium Bromide / Formoterol FumarateDrug

  • Salmeterol / FluticasoneDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak Forced Expiratory Volume in One Second (FEV1) at Week 24Time frame: At Week 24

Locations

126 sites in 14 countries. Site status is shown where the registry gives one.

  • Almirall Investigational Site

    Feldbach, Austria

  • Almirall Investigational Site

    Feldkirch, Austria

  • Almirall Investigational Site

    Grieskirchen, Austria

  • Almirall Investigational Site

    Linz, Austria

  • Almirall Investigational Site

    Salzburg, Austria

  • Almirall Investigational Site

    Dimitrovgrad, Bulgaria

  • Almirall Investigational Site

    Gabrovo, Bulgaria

  • Almirall Investigational Site

    Kozloduy, Bulgaria

  • Almirall Investigational Site

    Petrich, Bulgaria

  • Almirall Investigational Site

    Plovdiv, Bulgaria

  • Almirall Investigational Site

    Razgrad, Bulgaria

  • Almirall Investigational Site

    Stara Zagora, Bulgaria

  • Almirall Investigational Site

    Vidin, Bulgaria

  • Almirall Investigational Site

    Edmonton, Alberta, Canada

  • Almirall Investigational Site

    Vancouver, British Columbia, Canada

  • Almirall Investigational Site

    Vancouver, British Columbia, Canada

  • Almirall Investigational Site

    Moncton, New Brunswick, Canada

  • Almirall Investigational Site

    Toronto, Ontario, Canada

  • Almirall Investigational Site

    Saint Romuald, Quebec, Canada

  • Almirall Investigational Site

    Trois-Rivières, Quebec, Canada

  • Almirall Investigational Site

    Karlovy Vary, Czechia

  • Almirall Investigational Site

    Kralupy nad Vltavou, Czechia

  • Almirall Investigational Site

    Liberec, Czechia

  • Almirall Investigational Site

    Ostrava - Hrabuvka, Czechia

  • Almirall Investigational Site

    Rokycany, Czechia

  • Almirall Investigational Site

    Strakonice, Czechia

  • Almirall Investigational Site

    Nîmes, France

  • Almirall Investigational Site

    Perpignan, France

  • Almirall Investigational Site

    Vieux-Condé, France

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Berlin, Germany

  • Almirall Investigational Site

    Bochum, Germany

  • Almirall Investigational Site

    Bonn, Germany

  • Almirall Investigational Site

    Cologne, Germany

Showing 40 of 126 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.